Skip to content

Radical Prostatectomy and Perioperative Fluid Therapy

Radical Prostatectomy and Perioperative Fluid Therapy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00771966
Enrollment
44
Registered
2008-10-15
Start date
2008-10-31
Completion date
2009-10-31
Last updated
2012-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

patients with cancer in the prostate

Brief summary

The optimal amount of fluid a patient need under surgery is not clear. Both to much and to little fluid can damage the organ functions. A strategy called Goal directed therapy, where the fluid amount a patient need is guided by the stroke volume, has shown to minimize post-operative nausea and vomiting. The investigators intend to investigate if patients treated after these standards, has a better outcome then patients treated after normal regimes, regarding post-operative orthostatic-intolerance.

Interventions

PROCEDUREStandard therapy

Standard therapy

PROCEDUREMaximization of cardiac stroke volume with fluid infusion

Maximization of cardiac stroke volume with fluid infusion

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with cancer in there prostate

Exclusion criteria

* Patients who don't understand the information * ASA \> III * Patients that are under treatment with the drug triazolam * Patients with af known renal decease * Patients with a psychiatric decease * Alcohol abuse * Severe haemorrhagic decease * Cancer in the mouth,pharynx, larynx or oesophagus

Design outcomes

Primary

MeasureTime frame
To investigate orthostatic cardiovascular response and orthostatic intolerance in patients after removal of the prostate6 hours

Secondary

MeasureTime frame
Investigate intraoperative haemodynamicsIntraoperative

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026